Concord Wealth Partners’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-3
Closed -$201 – 876
2023
Q3
$201 Hold
3
– – ﹤0.01% 1011
2023
Q2
$203 Buy
+3
New +$188 ﹤0.01% 1019
2023
Q1
– Sell
-3
Closed -$179 – 1050
2022
Q4
$179 Buy
+3
New +$163 ﹤0.01% 1211
2022
Q3
– Sell
-67
Closed -$3K – 426
2022
Q2
$3K Buy
+67
New +$3.44K ﹤0.01% 928
2021
Q2
– Sell
-14
Closed -$1K – 1064
2021
Q1
$1K Buy
+14
New +$913 ﹤0.01% 902

Other funds holding EHC

Concord Wealth Partners's EHC Position: Q4 2023 in Review

Concord Wealth Partners sold out of Encompass Health (EHC) in Q4 2023, closing a stake of 3 shares — an estimated $201 sold.

Concord Wealth Partners first reported a position in EHC in Q1 2021 and held it in 5 quarters. The position peaked at $3K in Q2 2022. 435 funds tracked by Wall St. Rank hold EHC as of Q4 2023.

  • Concord Wealth Partners reported no remaining Encompass Health position as of Q4 2023 after selling out during the quarter.
  • Concord Wealth Partners sold 3 Encompass Health shares in Q4 2023, an estimated $201.
  • Concord Wealth Partners first reported a position in Encompass Health in Q1 2021 and held it in 5 quarters.
  • Concord Wealth Partners's Encompass Health position peaked at $3K in Q2 2022.
  • 435 funds tracked by Wall St. Rank held Encompass Health as of Q4 2023.

Based on Concord Wealth Partners's 13F filing for Q4 2023, filed 6 Feb 2024.